Knoll Capital Management, LLC
MIAMI, FL · CIK 1325083 · 13F filing filed 2020-05-15
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyMiami, FL
$106.5m
reported value
-21.4% vs Q4 2019
18positions
93.0%in top 10
1 new
2 added
1 reduced
1 sold out
vs Q4 2019
Holdings, Q1 2020
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $29.2m27.41% | Unchanged |
| CORBUS PHARMACEUTICALS HLDGS CRBP | $26.4m24.84% | Unchanged |
| APPLIED THERAPEUTICS INC APLT | $21.0m19.72% | Added +175.0k |
| ABEONA THERAPEUTICS INC COM | $6.0m5.64% | Unchanged |
| BLACKSTONE GROUP L P BX | $3.6m3.42% | Reduced -73.0k |
| ENTERA BIO LTD ENTX | $3.3m3.08% | Unchanged |
| EIGER BIOPHARMACEUTICALS INC CLDN | $3.2m3.04% | Added +125.0k |
| ANAVEX LIFE SCIENCES CORP AVXL | $2.3m2.14% | Unchanged |
| CENTURYLINK INC CTL | $2.1m1.95% | Unchanged |
| EXICURE INC XCUR | $1.9m1.78% | Unchanged |
| MOLECULAR TEMPLATES INC COM | $1.5m1.42% | Unchanged |
| ALDEYRA THERAPEUTICS INC ALDX | $1.4m1.32% | Unchanged |
| SOLIGENIX INC COM | $1.3m1.24% | Unchanged |
| DOW INC DOW | $877.0k0.82% | Unchanged |
| CORTEVA INC CTVA | $705.0k0.66% | Unchanged |
| CATASYS INC COM PAR | $655.0k0.62% | Unchanged |
| DUPONT DE NEMOURS INC DWDP | $512.0k0.48% | Unchanged |
| BIOXCEL THERAPEUTICS INC COM | $447.0k0.42% | New |
Sold out since Q4 2019
| Security | Value then |
|---|---|
| KRANESHARES TR KBA | $3.1m96.0k shares |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 | 5.3%≈ $4.7m |